India celebrates 1 billion COVID-19 vaccine doses with song and dance
By Krishna N. Das
NEW DELHI (Reuters) -India celebrated the milestone of administering 1 billion COVID-19 vaccine doses on Thursday, with the government promoting the achievement in song and video even as a recent drop in inoculations worries healthcare providers.
After a slow beginning in the middle of January, India's immunisation campaign has covered three-quarters of its 944 million adults with at least one dose but only 31% with two. The government wants all adults to get vaccinated this year.
"India scripts history," Prime Minister Narendra Modi said on Twitter. "We are witnessing the triumph of Indian science, enterprise and collective spirit of (1.3 billion) Indians."
Modi marked the occasion by interacting with healthcare workers and a security guard at a government hospital in New Delhi. The health ministry announced musical and other programmes across the country, and special illuminations of national monuments including a colonial-era jail.
Nearly 90% of the vaccines administered in India have come from the Serum Institute of India (SII), which produces a licensed version of the AstraZeneca drug. SII has more than tripled its capacity since April and can now produce 220 million vaccine doses a month.
SII has also slowly resumed exports for the first time since April, when the government stopped all overseas sales to meet domestic demand as infections rose dramatically.
The World Health Organization (WHO), which relies heavily on India for supplies to its global vaccine-sharing platform COVAX, congratulated the country for reaching the landmark.
"India's progress must be viewed in the context of the country's commendable commitment and efforts to ensure that these life-saving vaccines are accessible globally," said Poonam Khetrapal Singh, regional director WHO South-East Asia.
COVAX partner UNICEF also congratulated India and said it looked forward to "hearing details about the expected timeline and volumes of supplies to be made" to the global facility.
Reuters has reported that India has delayed supplies of the AstraZeneca vaccine to COVAX https://www.reuters.com/world/india/india-delays-covid-19-vaccine-supplies-who-backed-covax-sources-say-2021-10-19. New Delhi has been annoyed by the WHO's repeated delay in adding India's own Covaxin shot to the world body's emergency-use listing https://twitter.com/DrTedros/status/1450574012027920402, something both parties discussed this week as well as exports.
India has so far reported 34.1 million COVID-19 cases and more than 452,000 deaths, most during a second wave of infections of the Delta variant between April and May.
A "sizeable number https://www.reuters.com/article/health-coronavirus-india/many-indians-skipping-second-covid-shot-despite-record-vaccine-stocks-idUSL4N2RF2G3" of people in India have not taken their second dose by the due date despite adequate supplies, the health ministry said on Tuesday, as new infections fell to their lowest since early March.
Daily shots have averaged 5 million this month, a fifth of September's peak, though states are sitting on record stocks of more than 100 million as domestic output of the AstraZeneca vaccine soars.
Despite the current low number of infections, ministry officials have been urging people to get vaccinated fast, especially as the ongoing festival season means family gatherings and mass shopping, raising the risk of a new wave of infections.
(Reporting by Krishna N. Das; Editing by Lincoln Feast and Giles Elgood)
